These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35432218)

  • 41. Diverse
    Weigelt B; Comino-Méndez I; de Bruijn I; Tian L; Meisel JL; García-Murillas I; Fribbens C; Cutts R; Martelotto LG; Ng CKY; Lim RS; Selenica P; Piscuoglio S; Aghajanian C; Norton L; Murali R; Hyman DM; Borsu L; Arcila ME; Konner J; Reis-Filho JS; Greenberg RA; Robson ME; Turner NC
    Clin Cancer Res; 2017 Nov; 23(21):6708-6720. PubMed ID: 28765325
    [No Abstract]   [Full Text] [Related]  

  • 42. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
    Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
    Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low frequency of BRCA1 germline mutations in 45 German breast/ovarian cancer families.
    Hamann U; Häner M; Stosiek U; Bastert G; Scott RJ
    J Med Genet; 1997 Nov; 34(11):884-8. PubMed ID: 9391879
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.
    Tonin PN; Mes-Masson AM; Futreal PA; Morgan K; Mahon M; Foulkes WD; Cole DE; Provencher D; Ghadirian P; Narod SA
    Am J Hum Genet; 1998 Nov; 63(5):1341-51. PubMed ID: 9792861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation landscape of germline and somatic BRCA1/2 in patients with high-grade serous ovarian cancer.
    Eoh KJ; Kim HM; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    BMC Cancer; 2020 Mar; 20(1):204. PubMed ID: 32164585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PALB2 mutations in BRCA1/2-mutation negative breast and ovarian cancer patients from Poland.
    Kluska A; Balabas A; Piatkowska M; Czarny K; Paczkowska K; Nowakowska D; Mikula M; Ostrowski J
    BMC Med Genomics; 2017 Mar; 10(1):14. PubMed ID: 28279176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Germline BRCA1 mutation analysis in Indian breast/ovarian cancer families.
    Kumar BV; Lakhotia S; Ankathil R; Madhavan J; Jayaprakash PG; Nair MK; Somasundaram K
    Cancer Biol Ther; 2002; 1(1):18-21. PubMed ID: 12170759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using gene carrier probability to select high risk families for identifying germline mutations in breast cancer susceptibility genes.
    Chang-Claude J; Dong J; Schmidt S; Shayeghi M; Komitowski D; Becher H; Stratton MR; Royer-Pokora B
    J Med Genet; 1998 Feb; 35(2):116-21. PubMed ID: 9507390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
    Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico.
    Villarreal-Garza C; Alvarez-Gómez RM; Pérez-Plasencia C; Herrera LA; Herzog J; Castillo D; Mohar A; Castro C; Gallardo LN; Gallardo D; Santibáñez M; Blazer KR; Weitzel JN
    Cancer; 2015 Feb; 121(3):372-8. PubMed ID: 25236687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
    Papi L; Palli D; Masi L; Putignano AL; Congregati C; Zanna I; Marini F; Giusti F; Luzi E; Tonelli F; Genuardi M; Brandi ML; Falchetti A
    Cancer Genet Cytogenet; 2009 Nov; 195(1):75-9. PubMed ID: 19837273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional implications of BRCA1 for early detection, prevention, and treatment of breast cancer.
    Dapić V; Monteiro AN
    Crit Rev Eukaryot Gene Expr; 2006; 16(3):233-52. PubMed ID: 17073553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.
    Peixoto A; Salgueiro N; Santos C; Varzim G; Rocha P; Soares MJ; Pereira D; Rodrigues H; Bento MJ; Fráguas A; Moura G; Regateiro F; Castedo S; Teixeira MR
    Fam Cancer; 2006; 5(4):379-87. PubMed ID: 16826315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
    Górski B; Byrski T; Huzarski T; Jakubowska A; Menkiszak J; Gronwald J; Pluzańska A; Bebenek M; Fischer-Maliszewska L; Grzybowska E; Narod SA; Lubiński J
    Am J Hum Genet; 2000 Jun; 66(6):1963-8. PubMed ID: 10788334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers.
    Przybytkowski E; Davis T; Hosny A; Eismann J; Matulonis UA; Wulf GM; Nabavi S
    BMC Cancer; 2020 Mar; 20(1):197. PubMed ID: 32164626
    [TBL] [Abstract][Full Text] [Related]  

  • 57. BRCA1: the enigma of tissue-specific tumor development.
    Monteiro AN
    Trends Genet; 2003 Jun; 19(6):312-5. PubMed ID: 12801723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
    Buller RE; Lallas TA; Shahin MS; Sood AK; Hatterman-Zogg M; Anderson B; Sorosky JI; Kirby PA
    Clin Cancer Res; 2001 Apr; 7(4):831-8. PubMed ID: 11309330
    [TBL] [Abstract][Full Text] [Related]  

  • 59. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis.
    Welcsh PL; Lee MK; Gonzalez-Hernandez RM; Black DJ; Mahadevappa M; Swisher EM; Warrington JA; King MC
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7560-5. PubMed ID: 12032322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BRCA1 and BRCA2 germline mutation spectrum in hereditary breast/ovarian cancer families from Maghrebian countries.
    Cherbal F; Bakour R; Adane S; Boualga K
    Breast Dis; 2012; 34(1):1-8. PubMed ID: 23697973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.